Ascendis Health Ltd. (ASCENDIS) JSE:ASC share price - Click a Company

The latest financial information on the JSE listed company Ascendis Health Ltd. (ASC), including the stock price, historical share price performance charts, annual reports, market cap, consensus forecast and dividends.

JUMP TO: Sens Information Directors' Dealings List funds

/

Open:
Prev close:
Range:
Volume:
Ave trading volume:

Bid:
Bid volume:
Offer:
Offer volume:

52 week range:

Click and drag to zoom in on timeline.

	Intraday
	7 days
	30 days
	90 days
	6 months
	1 year
	YTD
	3 years
	5 years
	10 years
Graphs are updated every 5 minutes between 09:05 and 17:05 on weekdays. Move %s are calculated on the previous close price.

Compare

Indices

This consensus forecast was last updated on 2023/11/14

Consensus forecasts are supplied by third party analysts and calculated by our data feed providers. As the forecast is completely dependent on updates received, not all companies' consensus forecasts are updated regularly.

Market cap:	455,378,370
EPS - TTM:	-1.4
P/E ratio:	-51.43
Forward P/E:	6.55
Dividend yield:	0 %
Return on equity:	9.27 %
Return on assets:	3.83 %
Net asset value:	98.76
Price/NAV:	0.73
Authorised shares:	2,000,000,000
Issued shares:	632,469,959

Price data is updated daily.

Report	Date
ASC - Annual Report June 2024	2024/06/30
ASC - Annual Report June 2023	2023/06/30
ASC - Annual Report June 2022	2022/06/30
ASC - Annual Report June 2021	2021/06/30
ASC - Annual Report June 2020	2020/06/30

The road to NHI needs a safety belt

30 Jul 2024 4

Litigation an option if NHI Bill is signed and promulgated this week – Busa

14 May 2024 5

Ramaphosa set to sign NHI Bill into law

UPDATE

13 May 2024 23

AI-driven healthcare in SA, what are the ethical considerations?

16 Jan 2024

NCOP passes contentious NHI Bill

UPDATE

6 Dec 2023 21

JSE to lose another listing

28 Sep 2023 1

31.10.24 17:00

ASCENDIS HEALTH LIMITED – Distribution of notice of annual general meeting and availability of integrated annual report

23.10.24 09:25

ASCENDIS HEALTH LIMITED – Transfer to the General Segment of the Main Board of the JSE Limited

04.10.24 17:35

ASCENDIS HEALTH LIMITED – Availability of the audited annual financial statements and no change statement

26.09.24 08:15

ASCENDIS HEALTH LIMITED – Dealings in securities by an associate of a director & disclosure of acquisition of securities

19.09.24 13:20

ASCENDIS HEALTH LIMITED – Disclosure of disposal and acquisition of securities

17.09.24 12:28

ASCENDIS HEALTH LIMITED – Dealings in securities by an associate of a director

09.09.24 07:40

ASCENDIS HEALTH LIMITED – Dealings in securities by associates of a director and a director

03.09.24 12:30

ASCENDIS HEALTH LIMITED – Reviewed condensed consolidated financial statements for the year ended 30 June 2024

30.08.24 12:25

ASCENDIS HEALTH LIMITED – Trading statement for the year ended 30 June 2024

06.08.24 17:42

ASCENDIS HEALTH LIMITED – Appointment of the interim chief financial officer

Sector: Pharmaceuticals and Biotechnology

Company / Share

Price / Move

NUMERAL

ASCENDIS

ASPEN

ADCOCK

'000 Rands	Jun 24 F	Dec 23 I
Turnover	1,472	738
Op Inc Operating Income	46	48
Att Inc Income Attributable To Equity Holders	57	80
Cash Gen PS Cash Generated Per Share	-0.79	-4.11
Cshflo frm ops Net Cash flow from operating activities	-5	-26
Oper Pft Mgn Operating Profit Margin	3.15 %	6.46 %

'000 Rands	Jun 24 F	Dec 23 I
Fixed Ass Fixed Assets	196,617	195,878
Tot Curr Ass Total Current Assets	768,509	814,376
Ord SH Int Ordinary Shareholders' Interest	618,270	642,427
	0	0
LT Liab Total Long-Term Liabilities	35,708	43,595
Tot Curr Liab Total Current Liabilities	408,872	436,015

	Jun 24 F	Dec 23 I
EPS (ZARc) Earnings Per Share (ZARc)	9.2	12.7
HEPS-C (ZARc)	-1.4	10.2
	0	0
NAV PS (ZARc) Net Asset Value Per Share (ZARc)	98.76	102.62
Ret on SH Fnd Return on Shareholder Funds	9.27 %	24.76 %
Ret On Tot Ass Return on Total Assets	3.83 %	11.07 %

Next AGM date: Friday, 29 November 2024, confirmed
Interim results estimated to be released on 28 March 2025

Here is a list of South African unit trusts holding this share. These tables reflect changes in holdings over two quarters, but do not show where a fund has completely sold a holding during the latest quarter.

Holdings	Jun 2024		Mar 2024		Unit change	Value change (R'000s)	% of Fund	manco	link	code
Holdings	# Units	Value (R'000s)	# Units	Value (R'000s)	Unit change	Value change (R'000s)	% of Fund	manco	link	code
Excelsia Balanced 27four Fund	1,476	11.510	1,476	11.960	0	-0.450	0.0988	Fund managed by 27four Collective Investments (RF) (Pty) Ltd.	Excelsia Balanced 27four Fund (A1) - EXBFA1	excelsia-balanced-27four-fund
Excelsia Equity 27four Fund	268,907	2,097.470	278,336	2,254.520	-9,429	-157.050	0.2741	Fund managed by 27four Collective Investments (RF) (Pty) Ltd.	Excelsia Equity 27four Fund (A1) - EEACA1	excelsia-equity-27four-fund
Total

The free version only lists 5 unit trusts. Subscribe to see the full list.

SUBSCRIBE NOW

Share	Declared date	Last day to trade	Pay date	Type	Value
ASCENDIS	2017/03/08	2017/05/09	2017/05/15	Interim	11 ZARc

Date

Beneficiary

Deal Type

Value

Volume

Price

2024/09/23

Associate

Buy (SENS)

1,110,000

1,500,000

0.74

2023/11/28

Associate

Buy (SENS)

9,302,292

11,668,705

0.80

2023/06/15

Associate

Buy (SENS)

481,707

778,580

0.62

2023/03/28

Associate

Buy (SENS)

176,010

289,158

0.61

2023/01/30

Associate

Buy (SENS)

3,986

6,535

0.61

2022/12/23

Wellner, Karsten U H

Option (SENS)

204,000

400,000

0.51

2022/12/02

Wellner, Karsten U H

Option (SENS)

77,866

109,671

0.71

2022/10/27

Associate

Buy (SENS)

1,970,311

2,897,516

0.68

2022/10/27

Associate

Buy (SENS)

1,970,312

2,897,517

0.68

2022/05/13

Associate

Sell (SENS)

643,348

960,221

0.67

Nature of business
Ascendis Health is a health and wellness investment holding company marketing and distributing a portfolio of leading brands, products and medical devices.

Company email
[email protected]

Company website
http://www.ascendishealth.com

Transfer secretary
Computershare Investor Services (Pty) Ltd.

Company secretary
Joseph Fine

Postal address
PostNet Suite 252, Private Bag X21, Bryanston, 2021

Registered address
1 Carey Street, Wynberg, Sandton, 2191

Company tel
011 036-9600

Company fax

Major shareholders
Calibre Investment Holdings (Pty) Ltd., International Finance Corporation, Kefolile Health Investments (Pty) Ltd., Cresthold (Pty) Ltd., Kingston Kapitaal (Pty) Ltd., Dendrobium Capital (Pty) Ltd., Carl Andre Capital (Pty) Ltd., Blee Beleggings (Pty) Ltd.

This consensus forecast was last updated on 2023/11/14

Market cap:	455,378,370
EPS - TTM:	-1.4
P/E ratio:	-51.43
Forward P/E:	6.55
Dividend yield:	0 %
Return on equity:	9.27 %
Return on assets:	3.83 %
Net asset value:	98.76
Price/NAV:	0.73
Authorised shares:	2,000,000,000
Issued shares:	632,469,959

Price data is updated daily.

Report	Date
ASC - Annual Report June 2024	2024/06/30
ASC - Annual Report June 2023	2023/06/30
ASC - Annual Report June 2022	2022/06/30
ASC - Annual Report June 2021	2021/06/30
ASC - Annual Report June 2020	2020/06/30